Pet generics: The next frontier

It's a given that human drugs will have a generic alternative as soon as the original's patent expires. For pet medicines, however, that's true only about six percent of the time. Enter three-decade pharma exec Jean Hoffman, who paid full boat for drugs to help her elderly cat, Dude. Hoffman launched Putney in Portland, ME, in 2006; she anticipates $13 million in sales in 2010, rising to more than $100 million by 2013. Story

Suggested Articles

Fujifilm Diosynth Biotechnologies last year committed 10 billion yen toward its manufacturing operations. It has now kicked off one of those projects.

Popular logic says you never switch horses, or CDMOs, in the middle of the stream, but Acacia Pharma had to do that to win an FDA approval.

The FDA has found issues with the testing practices of a U.S. generics maker that had specific problems with ADHD and weight-loss drugs.